FDA Inspection
New York Blood Center EnterprisesNew York Blood Center Enterprises – FDA Inspection, Dec 9, 2010
Record Details
This FDA Inspection record concerns New York Blood Center Enterprises, with an inspection on December 9, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- December 9, 2010
- Product Type
- Biologics
View Company Profile
ID · 73d3b19a-f6af-417a-9635-3628a0da597c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 700863
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Blood Center Enterprises
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 11, 2026 | Not classified | New York District Office | Blood and Blood Products |
| November 5, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 7, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 2, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 20, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center Enterprises
- FDA Inspection 1302348 - 2026-02-11
- FDA Inspection 1132998 - 2020-11-05
- FDA Inspection 1040884 - 2018-02-07
- FDA Inspection 952436 - 2015-12-02
- FDA Inspection 892079 - 2014-08-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.